企業プロフィール
ATAI Life Sciences 株価・ニュース・カタリスト
- ティッカー:
- ATAI
- 取引所:
- NASDAQ
- セクター:
- Life Science Tools
- 所在地:
- Germany with U
株価パフォーマンス
7.24 USD (-0.28%)
終値
最終更新: 2026年8月17日
1.77B USD
時価総額
株価変動の要因
As of Aug 17, 2026, ATAI closed down 0.28% at $7.24. No new same-company headline was identified in the current news window.
企業概要
事業概要
atai Life Sciences is a mental-health company building a portfolio around psychedelic and novel neuropsychiatric therapies. Its story is centered on the possibility of new treatment paradigms for depression and related disorders.
所在地とセクター分類
Headquartered in Germany with U.S. market exposure and listed on NASDAQ as an ADR, atai has a global mental-health biotech profile.
ビジネスモデルの特徴
The company depends on clinical data, regulatory progress, and the commercial viability of novel psychiatric treatments.
バイオ業界での位置付け
atai is a high-catalyst CNS name with strong sensitivity to clinical and regulatory outcomes.
今後のカタリスト
- ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter. The stock will move if the clinical path keeps looking more practical and less experimental.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。